Glycogen

Biochemistry1 min read
On this page 2 sections

Glycogen Storage Diseases

Glycogen storage diseases (GSDs) result from defects in enzymes responsible for glycogen synthesis or breakdown. They commonly affect the liver, skeletal muscle or both.

TypeDiseaseEnzyme defectHigh-yield features
IVon GierkeGlucose-6-phosphatase systemSevere fasting hypoglycemia, lactic acidosis, hepatomegaly
IIPompeLysosomal acid α-glucosidaseCardiomyopathy, hypotonia and muscle weakness
IIICori/ForbesDebranching enzymeHepatomegaly, fasting hypoglycemia and limit-dextrin accumulation
IVAndersenBranching enzymeAbnormal glycogen structure and progressive liver disease
VMcArdleMuscle glycogen phosphorylaseExercise intolerance, cramps and myoglobinuria
VIHersLiver glycogen phosphorylaseMild fasting hypoglycemia and hepatomegaly

Clinical distinctions

Von Gierke disease (Type I)

  • Severe fasting hypoglycemia.
  • Hepatomegaly.
  • Lactic acidosis.
  • Hyperuricemia and hyperlipidemia may occur.

Pompe disease (Type II)

  • Lysosomal glycogen accumulation.
  • Infantile disease may produce severe cardiomyopathy and hypotonia.
  • Unlike many hepatic GSDs, fasting hypoglycemia is not the defining feature.

Cori disease (Type III)

  • Debranching enzyme deficiency.
  • Incomplete glycogen breakdown.
  • Hepatomegaly and hypoglycemia; muscle involvement may occur.

McArdle disease (Type V)

  • Skeletal muscle glycogen cannot be used normally during exercise.
  • Exercise-induced cramps and fatigue.
  • Myoglobinuria can follow strenuous exercise.
  • A second-wind phenomenon may occur as muscles increasingly use circulating fuels.

Exam tip: Match the organ affected, fasting glucose pattern and enzyme defect. These three clues usually distinguish the classic glycogen storage diseases.